Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer

Peer Review reports

Original Submission
8 Apr 2020	Submitted	Original manuscript
9 May 2020	Reviewed	Reviewer Report
5 Jun 2020	Reviewed	Reviewer Report
25 Jun 2020	Author responded	Author comments - Masaaki Miyo
Resubmission - Version 2
25 Jun 2020	Submitted	Manuscript version 2
14 Jul 2020	Author responded	Author comments - Masaaki Miyo
Resubmission - Version 3
14 Jul 2020	Submitted	Manuscript version 3
Publishing
15 Jul 2020	Editorially accepted
23 Jul 2020	Article published	10.1186/s12885-020-07186-5

Back to article page